Related Experiment Video

Updated: Jul 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

[p53-SOAT1 Axis: A Novel Target for Tumor Lipid Metabolism and Therapy]

Xi Yu1, Yuting Xiao1, Bowen Xu1

  • 1Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266000, China.

Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|March 4, 2026
PubMed

Insights

Abnormal lipid metabolism fuels cancer growth. This review explores the p53-SOAT1 axis, a key regulator of cellular lipids, highlighting its potential as a novel cancer treatment target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Research

Background:

  • Abnormal lipid metabolism is a hallmark of cancer, supporting tumor growth and progression.
  • The tumor suppressor p53 protein and sterol O-acyltransferase 1 (SOAT1) are critical regulators of cellular lipid metabolism.
  • Dysregulation of p53 and SOAT1 is linked to various cancers, impacting patient prognosis.

Purpose of the Study:

  • To review the current understanding of p53 protein and SOAT1 in tumor lipid metabolism.
  • To elucidate the potential mechanisms of the p53-SOAT1 axis in cancer development.
  • To explore the therapeutic potential of targeting the p53-SOAT1 axis in cancer treatment.

Main Methods:

  • Literature review of recent research on p53, SOAT1, and tumor lipid metabolism.
  • Analysis of signaling pathways involved in p53-mediated lipid regulation.
  • Examination of SOAT1's role as a key enzyme in cholesterol esterification within tumors.

Main Results:

  • p53 influences tumor lipid metabolism via multiple signaling pathways.
  • SOAT1 is highly expressed in many tumors, promoting tumor progression through cholesterol esterification.
  • Emerging evidence suggests a functional interplay between p53 and SOAT1 in maintaining tumor lipid homeostasis.

Conclusions:

  • The p53-SOAT1 axis represents a significant coordinating mechanism for lipid metabolism in cancer cells.
  • Targeting the p53-SOAT1 pathway holds promise for developing novel anti-cancer therapies.
  • Further research into this axis could uncover new strategies to overcome drug resistance and improve treatment outcomes.
Keywords:
Lipid metabolismSOAT1Tumorp53

More Related Videos

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...